Clinical Genomics Market
Meticulous Research® –
one of the leading global market research companies published a research report
titled “Clinical Genomics Market by Test Type (Diagnostic, Genetic, Newborn
Screening, Prenatal, Carrier Screening), Software, Method (Molecular,
Chromosomal, Biochemical Tests), End User (Hospitals & Clinics) – Global
Opportunity Analysis and Industry Forecast to 2023”
The Driving Forces in the
Clinical Genomics Market
According
to this latest publication from Meticulous Research®, the global
clinical genomics market will grow at a CAGR of 17.1% from 2018 to 2023 to
reach USD 879.0 million by 2023, driven by growing significance of early
disease detection and prevention, rising insistence for precision medicine,
increasing application of genetic testing in oncology, and favourable
reimbursement scenario related to genetic testing. However, the enormous cost
of genetic testing, and social and ethical implications hinders the growth of
clinical genomics market to some extent.
Key Market Segments to
Watch
The global clinical
genomics market is mainly segmented by test type (diagnostic testing, genetic
testing, newborn screening, prenatal testing, preimplantation testing, carrier
screening and other tests), software, method (molecular tests, chromosomal
tests, biochemical tests), end user (hospitals & clinics, government
laboratories & research centers, academics and research institutes and
other end users) and geography.
Regional Market Growth
Trends
Geographically, the
global clinical genomics market is segmented into North America (U.S. and
Canada), Europe, Asia Pacific, and Rest of World. North America held the major
share in the global clinical genomics market, followed by Europe, and
Asia-Pacific. Public awareness regarding genetic testing, high burden of
chronic and infectious diseases, increasing R&D expenditure, and various
government initiatives are the major factors fueling the growth of market in
North America. However, Asia-Pacific region possesses lucrative growth potential
for the clinical genomics market during the forecast period. This is mainly
attributed to the increasing population, rising rate of diseases, and various
government initiatives for the genomic research to understand the complex
biological process and genetic mutations present in life-threatening diseases,
which can reduce rising rate of chronic diseases and infectious diseases in
this region.
Speak to Analyst: https://www.meticulousresearch.com/speak-to-analyst/?cp_id=3763
Leading Companies in the
Global Clinical Genomics Market
The key players in the
global clinical genomics market are Quest Diagnostics Incorporated (U.S.),
Eurofins Scientific SE (Luxembourg), Illumina, Inc. (U.S.), PerkinElmer,
Inc. (U.S.), NeoGenomics Inc. (U.S.), Foundation Medicine, Inc. (U.S.), Rosetta
Genomics Ltd. (Israel), Invitae Corporation (U.S.), Myriad Genetics, Inc.
(U.S.), Natera, Inc. (U.S.), Genomic Health, Inc. (U.S.), OPKO Health, Inc.
(U.S.), Centogene AG (Germany), Clinical Genomics Pty Ltd. (Australia),
23andMe, Inc. (U.S.), Iverson Genetic Diagnostics, Inc. (U.S.), Veritas
Genetics (U.S.), Gene by Gene, Ltd. (U.S.), GenomeDx Biosciences, Inc.
(Canada), MedGenome (India), Strand Life Sciences Pvt. Ltd. (India), Beijing
Genomics Institute (BGI) (China), Retrogen, Inc. (U.S.), Personalis, Inc.
(U.S.), and PathGroup (U.S.).
About Meticulous Research®
Meticulous Research® is
founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in
2013 as a private limited company under the Companies Act, 1956. Since its
incorporation, the company has become the leading provider of premium market
intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle
East & Africa.
Contact
Us:
Viren Shrivastava
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email:
viren@meticulousresearch.com
Comments
Post a Comment